Atlas Trials

A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia

Clinical trial NCT04780841 · COMPLETED

Trial details

NCT number
NCT04780841
Sponsor
Ardelyx
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperkalemia
Start date
2021-01-11
Primary completion
2021-12-28
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.